Navigation Links
Study reveals gender bias of prospective parents
Date:12/19/2011

A Queen's University study has found that when people think about having children, men want boys and women want girls.

"Gender neutrality - a lack of preference - is now a standard cultural norm embraced within most wealthy developed countries like Canada," says Lonnie Aarssen, a Queen's biology professor and co-author of the study. His results, though, reveal a strong gender bias, despite the researchers' prediction that they would find evidence of a well-established contemporary culture of gender neutrality.

As a way of explaining these findings, Dr. Aarssen says the results are consistent with the notion that people have a strong intrinsic desire to leave something of themselves behind, a "meme", for the future. "Our results show that men today envision this through sons while women visualize it through daughters."

Historically, Dr. Aarssen says both men and women indicated a strong preference for sons, and this has evolutionary roots connected with the fact that males have a nearly limitless capacity to father future offspring and advance the family line. "Now that women are empowered like never before in history, they are free to anticipate and realize their vision for legacy, expressly through opportunities now more widely available to their own gender," he says.
'/>"/>

Contact: Anne Craig
anne.craig@queensu.ca
613-533-2877
Queen's University
Source:Eurekalert

Page: 1

Related biology news :

1. Wayne State study finds soybean compounds enhances effects of cancer radiotherapy
2. Study of skates and sharks questions assumptions about essential genes
3. Close family ties keep microbial cheaters in check, study finds
4. Barracuda babies: Novel study sheds light on early life of prolific predator
5. New study shows promise for preventing preterm births
6. 3-year study identifies key interventions to reduce maternal, newborn and child deaths
7. London researchers lead innovative new cancer treatment study
8. Study finds increasing atmospheric concentrations of new flame retardants
9. Fate Therapeutics Announces Promising Data From Phase 1b Study of ProHema at the 2011 American Society of Hematology Annual Conference
10. New Study Shows Impact of Employee Wellness Efforts
11. New study provides comprehensive view of the status of Atlantic bluefin tuna
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2016)... Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring announced that after ... secured the final acceptance by all three (3) ... Systems (MAS) installed. Furthermore, Securus will have contracts ... by October, 2016. MAS distinguishes between legitimate wireless ...
(Date:6/9/2016)... attendance control systems is proud to announce the introduction of fingerprint attendance control software, ... employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - http://photos.prnewswire.com/prnh/20160609/377487 ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: